Tuesday, April 09, 2024 6:57:03 PM
Natural Harmony Foods Inc. Signs US$5,000,000 Equity Facility to Fund GrowthPress Release | 11/16/2023
NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Publicly-held Natural Harmony Foods, Inc. (OTC PINK:NHYF) ("the Company") is pleased to announce today that it has entered into a Securities Purchase and Subscription Agreement with Global Corporate Finance Inc. ("GCF"), an esteemed private family office located in New York City, to provide working capital that will underpin the Company's growth.
?
The Securities Purchase and Subscription Agreement will enable the Company to draw up to US$5,000,000 at its discretion over a period of 30 months. In return for each drawdown, the Company will issue common stock at discount of 9% to the Company's average daily volume weighted stock price during the five (5) consecutive trading days immediately preceding the date of the Company's drawdown request. The cost of securing the facility is considered to be appropriate for the transaction.
The funds will be used to launch the first of the Company's nutraceutical products; the acquisition and development (subject to due diligence) of AI-based intellectual property; and general working capital, including up-listing the Company to OTCQB status as quickly as possible.
Mr. Randy Rivera, Director of Global Corporate Finance, said:
"The investment in NHYF is a logical step in GCF's strategy to invest in companies at the forefront of AI-powered medical technology. Companies with unique strategic investments in the AI medtech space have the potential to develop significant value over the next two to five years and we look forward to a long and productive association with NHYF".
Mr. Claudio Solitario, CEO of Natural Harmony Foods Inc. adds:
"We are delighted to be partnering with Global Corporate Finance Inc. and are very grateful for their financial support. The facility will provide the capital required to execute our growth plans and build shareholder value. Our collaboration with GCF is a testament to our shared vision for innovation and growth. The capital will serve as a dynamic catalyst to propel our strategic initiatives forward. We too look forward to a long and productive working relationship with GCF".
For media and Investor Relations inquiries, please contact: ir@nhyf.net
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM